Lockheed Martin Is A Buy - Cramer's Lightning Round (2/23/16)

by: SA Editor Mohit Manghnani


Palo Alto Networks is a good company, richly valued but not suitable for the current market.

Immunotherapy stocks are risky to buy.

Retail cohort is down and there is too much competition.

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday, February 23.

Bullish Call

Lockheed Martin (NYSE:LMT): This is a terrific stock at current levels and is also a key position for Cramer's charitable trust.

Bearish Calls

Micron Technology (NASDAQ:MU): Don't touch Micron when there are high-quality stocks like Skyworks Solutions (NASDAQ:SWKS).

Fortinet (NASDAQ:FTNT): "The only one of these that we are recommending right now is Palo Alto Networks (NYSE:PANW)." The stock is richly valued and it is not the kind of environment where such stocks are bought.

Kite Pharma (NASDAQ:KITE): All immunotherapy stocks are risky. Stocks like Celgene (NASDAQ:CELG) cannot withstand the environment and Kite is way down the food chain.

Barrick Gold (NYSE:ABX): Longer term, this stock has been a disaster. Cramer likes Randgold Resources (NASDAQ:GOLD).

Chico's FAS (NYSE:CHS): There too many apparel retailers and the entire cohort is down.


Jim Cramer's Action Alerts PLUS: Check out Cramer's multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - It's free and takes only a few seconds to sign up.